EDP-514, A NOVEL PANGENOTYPIC CLASS II HEPATITIS B VIRUS CORE INHIBITOR: PRELIMINARY RESULTS OF A 28-DAY PHASE 1b STUDY IN NUC-SUPPRESSED CHB PATIENTS

Media coverage

• Title	EDP-514, A NOVEL PANGENOTYPIC CLASS II HEPATITIS B VIRUS CORE INHIBITOR: PRELIMINARY RESULTS OF A 28-DAY PHASE 1b STUDY IN NUC-SUPPRESSED CHB PATIENTS
  Media name/outlet	National AIDS Treatment Advocacy Project
  Country/Territory	United States
  Date	15/12/21
  URL	https://www.natap.org/2021/AASLD/AASLD_150.htm
  Persons	Douglas Dieterich, Paul Martin